Inveready Technology Investment Group — 2026 Investments

2 investments dated 2026 · listed companies and verified rows first · show all

Iteria Biopharmaiteriabiopharma.comSeed · Apr 2026 · $6M

Iteria Biopharma is a biotech company developing first-in-class new chemical entities that use medicinal chemistry to modulate difficult drug targets, aimed at treating cancers with high unmet medical need.

BiotechHealthtechGalicia, ES

Julio CastroRamon Bosser

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Connecta Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.